Physician profile
Reagan E Tipton
NPI 1487622544
$1,510.16
in general payments reported to CMS, 2019-2025
20 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $50.81 · 2021: $173 · 2022: $266 · 2023: $403 · 2024: $213 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $288.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $168.33 | 2021-2025 | |
| Abbvie INC. | $164.03 | 2021-2023 | Ubrelvy |
| Lilly USA, LLC | $139.51 | 2022-2024 | Mounjaro, Trulicity, Zepbound |
| Astellas Pharma US INC | $126.37 | 2023-2024 | Veozah |
| Abbott Laboratories | $92.29 | 2021-2023 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.20 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $74.25 | 2022-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $72.71 | 2021-2025 | Gardasil 9, Vaxelis, Proquad |
| Amarin Pharma, INC. | $58.29 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $49.22 | 2021-2022 | |
| Exact Sciences Corporation | $32.48 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $32.23 | 2020 | |
| Cipher Pharmaceuticals US LLC | $21.55 | 2025 | Spinosad, Natroba |
| Radius Health, INC. | $20.07 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.58 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.48 | 2025 | Xifaxan |
| Dexcom, INC. | $16.79 | 2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $15.70 | 2022 | |
| Sanofi Pasteur INC. | $15.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reagan Tipton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.